Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
60-00-4
Name of the chemical
ethylenediaminetetraacetic acid
Concentration
N/A
EC/CAS
25013-16-5
Name of the chemical
tert.-Butylhydroxyanisole (BHA); tert-butyl-4-methoxyphenol
Concentration
N/A
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
N/A
General Information
Revision date
2024-04-17
Product name
Indomethacin Suppositories USP 50 mg
1.2.1 Relevant identified uses
Pharmaceutical Product
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Potential Acute Health Effects
Very hazardous in case of ingestion. Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of inhalation. Severe over-exposure can result in death.
Potential chronic health
Effects Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one or many human organs. CARCINOGENIC EFFECTS Not available MUTAGENIC EFFECTS Mutagenic for bacteria and/or yeast TERATOGENIC EFFECTS DEVELOPMENTAL TOXICITY Not available
